Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real-world data (ACES).
Prantik DasSarah TaylorJames PriceMichael JonesCristina Martin-FernandezAkram AliThangrarajh MugunthanChandrani MallikColin WardPublished in: BJUI compass (2020)
This study showed a statistically significant difference in bPFS, favoring ENZ, but no significant difference in rPFS or OS.